On May 31, 2022, Oncocross Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,800 KRW | -10.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 7.09M | |
-15.96% | 987M | |
+39.05% | 948M | |
-4.39% | 459M | |
-14.93% | 403M | |
-1.66% | 334M | |
-36.20% | 282M | |
-4.59% | 275M | |
-39.16% | 271M | |
+4.71% | 105M |
- Stock Market
- Equities
- A299670 Stock
- News SM VINA Co., Ltd.
- Oncocross Co., Ltd. announced that it has received KRW 1.600015235 billion in funding from SM VINA Co., Ltd., C&M Trading Co., Ltd., DB Korea Discovery Co., Ltd.